IL-17A Promotes the Migration, Invasion and the EMT Process of Lung Cancer Accompanied by NLRP3 Activation

BACKGROUND: Lung cancer is a deadly cancer worldwide, and its pathogenesis and treatment methods require continuous research and exploration. As a representative factor of adaptive immunity, the role of interleukin-17A (IL-17A) in lung cancer is still unclear. The purpose of the present study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenping, Xin, Miaomiao, Li, Qing, Sun, Linqian, Han, Xiao, Wang, Jibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637470/
https://www.ncbi.nlm.nih.gov/pubmed/36349316
http://dx.doi.org/10.1155/2022/7841279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637470/
https://www.ncbi.nlm.nih.gov/pubmed/36349316
http://dx.doi.org/10.1155/2022/7841279

Ejemplares similares